Adriana Carolina Gamboa

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Rebecca Anne Snyder · 2 shared papers, 2026 · strength 0.88
   • Paper Surgical Palliation for Pancreatic Cancer. DOI 10.1016/j.soc.2025.05.005↗
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
2. Matthew H. G. Katz · 2 shared papers, 2025–2026 · strength 0.48
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
   • Paper Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient recor… DOI 10.1016/j.jbi.2025.104935↗
3. Dan Zhao · 1 shared paper, 2026 · strength 0.25
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
4. Naruhiko Ikoma · 1 shared paper, 2026 · strength 0.25
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
5. Laura R. Prakash · 1 shared paper, 2026 · strength 0.25
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
6. Mahmoud Yousef · 1 shared paper, 2026 · strength 0.25
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
7. Michael P. Kim · 1 shared paper, 2026 · strength 0.25
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
8. Jeffrey E. Lee · 1 shared paper, 2026 · strength 0.25
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
9. Ching-Wei David Tzeng · 1 shared paper, 2026 · strength 0.25
   • Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
10. Hongfang Liu · 1 shared paper, 2025 · strength 0.23
    • Paper Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient recor… DOI 10.1016/j.jbi.2025.104935↗
11. Christina Lynn Roland · 1 shared paper, 2025 · strength 0.23
    • Paper Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient recor… DOI 10.1016/j.jbi.2025.104935↗
12. Liwei Wang · 1 shared paper, 2025 · strength 0.23
    • Paper Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient recor… DOI 10.1016/j.jbi.2025.104935↗
13. David A. Kooby · 2 shared papers, 2020 · strength 0.22
    • Paper The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? DOI 10.1007/s11605-019-04377-9↗
    • Paper Optimal timing and treatment strategy for pancreatic cancer. DOI 10.1002/jso.25976↗
14. Maria Citarella Russell · 2 shared papers, 2020 · strength 0.22
    • Paper The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? DOI 10.1007/s11605-019-04377-9↗
    • Paper Optimal timing and treatment strategy for pancreatic cancer. DOI 10.1002/jso.25976↗
15. Shishir Kumar Maithel · 2 shared papers, 2020 · strength 0.22
    • Paper The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? DOI 10.1007/s11605-019-04377-9↗
    • Paper Optimal timing and treatment strategy for pancreatic cancer. DOI 10.1002/jso.25976↗
16. Juan Manuel Sarmiento · 1 shared paper, 2020 · strength 0.12
    • Paper The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz? DOI 10.1007/s11605-019-04377-9↗
17. Mihir M. Shah · 1 shared paper, 2020 · strength 0.11
    • Paper Optimal timing and treatment strategy for pancreatic cancer. DOI 10.1002/jso.25976↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.